Literature DB >> 16557754

Characteristics of Endotoxin-Altering Fractions Derived from Normal Serum III. Isolation and Properties of Horse Serum alpha(2)-Macroglobulin.

M Yoshioka1, S Konno.   

Abstract

The endotoxin-altering activity of fractions isolated from normal horse serum was examined by incubation of Salmonella typhosa strain 0-901 endotoxin (Boivin) in a solution of the fraction, and subsequent quantitation of any diminution in the capacity of endotoxin to be precipitated by specific anti-endotoxin antiserum. The horse serum fraction isolated by precipitation with ammonium sulfate at a concentration between 1.6 and 2.7 m was incubated with Pronase PA and then with trypsin. When this partly digested fraction was passed twice through a Sephadex G-200 column and eluted with 0.2 m tris(hydroxymethyl)aminomethane buffer, most of the endotoxinaltering activity was found in the first protein peak designated F-1a. F-1a was found to be homogeneous and corresponded to an alpha(2)-macroglobulin by the techniques of electrophoresis, immunodiffusion, and ultracentrifugation. Approximately 100-fold more F-1a than endotoxin was needed to reduce the antigenicity of the endotoxin by one-half. Alteration was increased when F-1a was incubated with the endotoxin at acid pH or at 45 C rather than at 37 C and was lost after heating F-1a at 56 C for 30 min. N-ethylmaleimide increased the endotoxin-altering activity of horse serum, F-1a, and human plasma fraction III(0), whereas p-chloromercuribenzoate did not. On the other hand, diazonium-1-H-tetrazole, iodoacetic acid, and benzylchloride suppressed the activity of F-1a. When the interaction of endotoxin and F-1a was examined by immunodiffusion techniques, depolymerization of the endotoxin molecule was indicated. The endotoxin-altering factor of horse serum is discussed in relation to the mechanisms of other known reagents, such as deoxycholate and sodium lauryl sulfate.

Entities:  

Year:  1970        PMID: 16557754      PMCID: PMC415920          DOI: 10.1128/iai.1.5.431-439.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  REVERSIBLE INACTIVATION OF AN ENDOTOXIN BY INTRACELLULAR PROTEIN.

Authors:  S I OROSZLAN; P T MORA; M J SHEAR
Journal:  Biochem Pharmacol       Date:  1963-10       Impact factor: 5.858

2.  RELATIONSHIP BETWEEN PARTICLE SIZE AND BIOLOGICAL ACTIVITY OF E. COLI BOIVIN ENDOTOXIN.

Authors:  H BEER; T STAEHELIN; H DOUGLAS; A I BRAUDE
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

3.  REACTIVATION OF PAPAIN-TREATED ENDOTOXIN.

Authors:  J A RUDBACH; E RIBI; K C MILNER
Journal:  Proc Soc Exp Biol Med       Date:  1965-05

4.  CHARACTERISTICS OF ENDOTOXIN ALTERING FRACTIONS DERIVED FROM NORMAL SERUM. I. SEPARATION OF BETA LIPOPROTEINS AND LIPID FROM HUMAN SERUM FRACTIONS.

Authors:  M YOSHIOKA; M HAMASAKA; Y SAITO; S KONNO
Journal:  Kitasato Arch Exp Med       Date:  1963-12

5.  Characteristics of endotoxin altering fractions derived from normal human serum.

Authors:  M YOSHIOKA; A G JOHNSON
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

6.  Dissociation of the biological properties of bacterial endotoxin by chemical modification of the molecule.

Authors:  H H FREEDMAN; B M SULTZER
Journal:  J Exp Med       Date:  1962-12-01       Impact factor: 14.307

7.  The alteration of bacterial endotoxins by human and rabbit serum.

Authors:  J E STAUCH; A G JOHNSON
Journal:  J Immunol       Date:  1959-03       Impact factor: 5.422

8.  INACTIVATION OF GRAM-NEGATIVE BACTERIAL ENDOTOXINS BY PAPAIN.

Authors:  Y B KIM; D W WATSON
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

9.  Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma.

Authors:  R C SKARNES; F S ROSEN; M J SHEAR; M LANDY
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

10.  Inactivation of endotoxin by a humoral component. III. Role of divalent cation and a dialyzable component.

Authors:  F S ROSEN; R C SKARNES; M LANDY; M J SHEAR
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

View more
  5 in total

1.  Endotoxin-inactivating activity in normal and pathological human blood samples.

Authors:  T Obayashi; H Tamura; S Tanaka; M Ohki; S Takahashi; T Kawai
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

2.  Endotoxin testing revisited.

Authors:  A Sturk; J W ten Cate
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

3.  Preliminary studies on the synthesis of alpha2-macroglobulin by human lymphocytes in vitro.

Authors:  A M Tunstall; K James
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

4.  Effect of serum from various animal species on erythrocyte attachment of endotoxins and other bacterial antigens.

Authors:  M Praino; E Neter
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  Serum-free culture of hamster lymphoid cells and differential inhibition of lipopolysaccharide stimulation by isologous serum.

Authors:  J S Streilein; D A Hart
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.